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Adapting practice patterns to a managed 
environment: Carotid endarterectomy-- 
A case example 
Rober t  H .  Brook, MD,  ScD, Santa Monica, Calif 
The way American medicine is practiced is changing rapidly. By the beginning of the next 
century, most Americans may be enrolled in for-profit managed care plans in which 
physicians are responsible for both a budget and a population of patients. As health care 
is revolutionized, the overriding issue is whether the mission of health care organizations 
will be simply to contain costs, or whether it will be to increase the value (i.e., the quality) 
that we get for the money we are willing to spend on health care. The purpose of this article 
is to illustrate for carotid endarterectomy how quality can remain on the health care reform 
agenda. Vascular surgeons must assume aleadership role, and they must be Mlling to alter 
their practice patterns. More specifically, they should: (1) support and facilitate the 
development ofclinically-detailed multispecialty criteria that describe under what circum- 
stances carotid endarterectomy is both appropriate and necessary; (2) support the 
development ofa system for publicly reporting outcome data by physician and hospital; (3) 
support regionalization of carotid endarterectomy; (4) conduct a prospective assessment 
of appropriateness before the procedure isperformed; (5) consider changing the system by 
which carotid angiographies are read to increase their reliability; and (6) help develop a 
system to ensure that people who need carotid endarterectomy are offered the procedure. 
(J Vase Surg 1996;23:913-7.) 
care 
This article is about the changing medical envi- 
ronment. It  is written by an internist who serves as a 
gatekeeper for super subspecialists, namely, vascular 
surgeons. When I graduated from medical school over 
a quarter of a century ago, it was impossible to 
envision the changes in medical practice we sec today. 
Advances in the science of medicine, the technology 
of medicine, and the therapies we use are astonishing. 
Who would have imagined that noninvasive tech- 
niques could be used to see, in real time and in color, 
blood flowing through arteries? As amazing as these 
changes have been, however, perhaps the most strik- 
ing change that has occurred in the past quarter 
century is the way medicine is practiced. 
I am a professor of medicine at UCLA. Most of my 
patients are enrolled in for-profit managed care orga, 
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nizations, and my physician group is responsible for 
both a budget and a population of patients. We are at 
risk financially. To stay within our budget, we, the 
physician group (not the evil insurance company), use 
many utilization-review procedures to ensure that we 
expend our resources wisely) Thus although I am a 
full professor of medicine, I cannot refer my patient o 
a dermatologist for consultation unless the physician 
group approves that consultation through its utiliza- 
tion-review committee. The practice of medicine has 
been altered substantially, and it will continue to 
change in the near future. 
In the United States we are moving rapidly toward 
a system in which doctors will bc responsible not only 
for treating patients but also for determining who 
receives care and how much care they receive. Physi- 
cians will need to have and to use tools and techniques 
that ensure money is spent wisely. They will need to 
increase their productivity so that they obtain more 
value for the amount of money they have to spend. 
They will need to become more comfortable with 
consensus processes, guidelines, decision analysis, 
meta-analysis, and utility assessments if they are to 
successfully achieve amission of simultaneously man- 
aging patients and money. 
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As the world of health care changes, the question 
that overrides all others on the health reform table 
must surely be this: Is the goal of future health care 
organizations simply to reduce the rate of growth of 
health expenditures in the United States, or is it to 
increase the value (i.e., the quality) that we get for the 
money we are willing to spend on health care? The 
intent of this article is to illustrate how practice 
patterns might change if we elect to keep quality on 
the table, and, more specifically, what this might mean 
for a particular procedure: carotid endarterectomy. 
My hope is that vascular surgeons will assume a 
leadership role in maldng sure quality stays on the 
table. My fear is that if such leadership is not under- 
taken, we will see competition based on price alone, 
with very little attention paid to quality of care. To 
better understand the case example of carotid endar- 
terectomy, we need to first establish some facts and 
definitions with respect to both quality of care and the 
procedure itself. 
Quality and its components 
Quality of care, which can be measured, 2 consists 
of a number of components. The first is the necessity 
or appropriateness of performing a specific procedure 
on a specific patient. Necessity means that the proce- 
dure should be performed and that the physician has 
a moral obligation to offer the procedure to the 
patient (of course, the patient need not accept it). 
Appropriateness means that the benefit o the patient 
exceeds the risks, so that the procedure is worth 
doing. Ifa procedure isless than necessary or less than 
appropriate, it should not be administered. 3 Methods 
to measure appropriateness and necessity have been 
developed and have been applied to carotid endar- 
terectomy. 4,s MI necessary procedures are also appro- 
priate. For an appropriate procedure to be considered 
necessary, however, it must provide substantial ben- 
efit to almost all the people who receive it and it must 
represent he best therapeutic option, that is, an 
alternative procedure or therapy should not produce 
equivalent results. 
The second component of quality is the degree 
of excellence demonstrated in performing a neces- 
sary or appropriate procedure. I f  a procedure is 
necessary or appropriate, one would wish to have 
it executed in the best possible manner to obtain 
the best possible results (e.g., a low complica- 
tion rate, increased patient fimctional status and 
survival). The third component of quality, which 
I will not discuss in this paper, is patient satis- 
faction. 
Carotid endarterectomy 
What are the facts as wc know them today? For 
patients who are at high risk of a stroke or death from 
a cerebrovascular incident in the carotid circulation, 
carotid endarterectomy reduces the stroke and death 
rate and should be performed if sufficient disease is 
present in the carotid arteries to justify performing the 
operation and if the surgery is done well (i.e., the 
operation issafe and efficacious). This evidence comes 
from a number of randomized controlled clinical 
trials.6s We have very little evidence, however, egard- 
ing the effectiveness of carotid endarterectomy (i.e., 
how good or how useful it is) when it is performed by 
the average surgeon on the average patient who is an 
appropriate candidate for the surgery. We do know, 
from the only representative community data avail- 
able for patients in the United States over the age of 
65 years, that carotid endarterectomy as performed by 
the average surgeon in the average hospital has a 
complication rate that exceeds that reported in ran- 
domized clinical trials twofold to threefold. 9 The data 
on which this statement rests, however, are old and 
may be out of date. 
We also know that the number of carotid endar- 
terectomies performed in various cities, states, and 
medical service areas varies widely, 1° and we know that 
we cannot use standard structural characteristics 
about physicians, hospitals, or patients (such as the 
physician's age, where he or she graduated from 
medical school, or whether the hospital is a teaching 
or nonteaching hospital) to predict whether the 
procedure will be performed on appropriate pa- 
tients. 11-14 
Finally, we know from the only national study that 
has ever been conducted on carotid endarterectomy 
that a third of the procedures are performed inappro- 
priately, and another third are performed in cases in 
which the benefit and risk of the procedure are about 
equal. 9We also know that most of these less-than- 
appropriate carotid endarterectomies areperformed 
on people who have <50% stenosis in the carotid 
artery. 
In sum: carotid endarterectomy is an efficacious 
procedure when performed on the right patients by 
superb surgical teams. Most carotid endarterecto- 
mies, however, may be less than appropriate because 
either the wrong patients are being operated on, or 
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those patients who do undergo the surgery for the 
correct reasons are likely to be operated on by people 
who are getting results that are not good enough to 
justify the operation. Unfortunately, we cannot use 
structural measures to predict which physicians are 
likely to perform the procedure well or poorly. 
The dilemma 
Given this situation, what am I--a gatekeeper 
in a for-profit HMO--going to do? On the basis 
of data contained in journals such as the New 
England Journal of Medicine, when I have a pa- 
tient who has had a transient ischemic attack and 
has 75% stenosis of the right carotid, I should refer 
the patient o a vascular surgeon for a procedure that 
will ensure the patient's troke and death rate will 
decrease. However, on the basis of the data cited 
above (which indicate that the complication and 
death rate facing my patient may be much higher 
because a physician in my managed care organiza- 
tion may not produce results from carotid en- 
darterectomy asgood as those obtained in random- 
ized trials), perhaps I should treat my patient medi- 
cally. 
I basically do not have sufficient data to determine 
what to do, and I find myself in a terrible dilemma. On 
top of that, I am subject o a great deal of financial 
pressure--stay within a budget, save money. It is my 
belief that under such circumstances, the gatekeeper 
internist may argue that because average results indi- 
cate this procedure should not be done, I will not refer 
the patient o a vascular surgeon because I have no 
way oflmowing whether the surgeon can perform the 
operation in an excellent manner. I can justify this 
decision on moral and ethical grounds: without data 
on the quality of care my patient will receive, I should 
at least do no harm. I can argue that the decision is 
correct on a financial ground as well: my physician 
group will be better offfinancially. I might even argue 
that this is a correct decision on a population basis: the 
money saved from this procedure will be used for 
other treatments hat are clearly efficacious, uch as 
providing chemotherapy for women with early breast 
cancer. 
I believe it is incumbent on the vascular surgery 
community to alter this scenario and to make sure that 
a procedure such as carotid endarterectomy (which 
works when it is applied correctly and performed well) 
is offered to patients when it is neccssary. I would ask 
the vascular surgery community to considcr anumber 
of changes in thc way it does business. 
The role of the vascular surgeon 
First. The vascular surgery community should 
demand that up-to-date, explicit, clinically detailed 
multispecialty criteria re developed to describe under 
what circumstances carotid endarterectomy is both 
appropriate and necessary. The guidelines should 
clearly indicate when it would be unjustifiable not to 
offer a patient carotid endarterectomy on the basis of 
the benefits and risks that would occur to the patient. 
Doctors must be willing to go out on strike if they are 
unable to offer this procedure to patients who meet 
the necessary criteria. Methods that combine litera- 
ture analysis, decision analysis, outcome-evidence 
tables, and panel processes have been devised to make 
it possible to develop such criteria and keep them up 
to date. 4,~ It should become apriority of the vascular 
surgery community to make sure this happens. 
Second. The vascular surgery community must 
recognize that for this and many other vascular 
procedures, how well a procedure isperformed must 
be a primary criterion in determining whether it 
should be used. For this reason, a system to publicly 
report outcome data by physician and hospital must 
be developed. Standardized clinical data need to be 
collected that would allow adjustment for differences 
in case mix and comparison of expected outcomes 
with observed outcomes for each physician and hos- 
pital. Data based on these calculations need to be 
made available to referring physicians and patients o 
that they can choose a doctor and a hospital with 
confidence, knowing that a given procedure will be 
performed inan excellent manner. Such a confidence- 
building system has been developed for coronary 
artery bypass urgery in the state of New York? s This 
system has demonstrated that coronary artery bypass 
surgery can be performed well in all hospitals in New 
York that perform the operation, and publication of 
the results has resulted in an improvement in case- 
adjusted mortality rates36 
Third. To produce statistically valid outcome data 
(i.e., stroke and death data) for carotid endarterec- 
tomy, we need to reduce the wide dispersion in the 
performance of this operation. Currently, a large 
number of surgeons do very few procedures, and if 
one is going to produce statistically valid outcome 
data, the performance ofcarotid endarterectomy will
need to be concentrated in the hands of fewer 
physicians and fewer centers34 About 100,000 ca- 
rotid endarterectomies areperformed per year in the 
United States. Obtaining statistically valid outcome 
data means that no fewer than 500 to 1000 carotid 
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endarterectomies should be performed at any institu- 
tion that does this procedure. Combining these two 
facts means that, at the most, 200 hospitals in the 
United States should be performing carotid 
endarterectomy; the country would probably be bet- 
ter off i fonly 100 facilities performed this operation. 
The vascular surgery community should support 
regionalization of the procedure by working with 
leaders in the public and private sector to identify 
those hospitals and hospital staffwhose clinical com- 
petence and geographic location warrant heir selec- 
tion as a carotid endarterectomy center. 
Fourth. The appropriateness of the procedure 
should be explicitly measured and compared with the 
clinically-detailed guidelines discussed at the begin- 
ning of this section. It is vital that managed care plans 
and the population in general know that a risky 
procedure such as carotid endarterectomy is being 
performed only when medically justifiable clinical 
indications are present. Before a carotid endarterec- 
tomy is performed, the physician should record symp- 
toms, signs, and treatments and the results of tests 
such as carotid angiography, and should check these 
against an algorithm to make sure the patient has a 
clinical condition and a state of disease that justifies 
the use of the procedure. There is no need for an 
insurance company or an 800 number to determine 
whether the procedure should be performed; all that 
is needed is a computer containing the appropriate- 
ness algorithm and a surgeon and patient working 
together to collect and enter the relevant data. I f  the 
algorithm produces a less-than-appropriate score, but 
the physician chooses to proceed with the operation, 
he should enter into the medical record a specific 
justification of why he believes his patient has a clinical 
condition that is an exception to the guideline. 
Operations performed for less-than-appropriate rea- 
sons should occur less than 5% of the time and might 
stimulate peer review. If exceptions are clinically 
justifiable, then the written reason for this justification 
should be fed back into the guideline-setting process 
to improve it. 
Fifth. Because of the variability in reading the 
results of angiographies, vascular surgeons hould 
consider increasing the reliability of angiography 
readings so that they can correctly identify those 
patients who will benefit from carotid endarterec- 
tomy. This could be accomplished by making sure, 
through the use of a series of unknowns, that the 
vascular surgeon or radiologist who reads the angio- 
grams is capable of rendering an opinion as to whether 
sufficient disease ispresent to warrant an operation. In 
addition, it may be virtually impossible to assure 
sufficient reliability with only a single reading of the 
angiography films. Two or even three readers, each 
rendering an independent opinion regarding the 
amount of disease in the vessel, might be required. In 
other words, it is time to seriously consider the 
information we have about lack of reliability in the 
medical field and to alter our practice patterns based 
on this information. 17,1s 
Sixth. Because considerable financial pressure will 
exist to reduce the use of procedures over the next 
decade, vascular surgeons must take a leadership role 
in ensuring that people who need carotid endarterec- 
tomy are identified and receive the operation. In a 
study we conducted on coronary artery bypass ur- 
gery, we found that 25% of people who had three- 
vessel or left main coronary artery disease were not 
offered coronary artery bypass urgery, even though 
they had no clinical condition that would warrant not 
performing the operation) 9 We also found that pa- 
tients who were not offered the procedure died at a 
relative rate twice as great as patients who received the 
procedure. Thus it is incumbent on vascular surgeons 
to help develop systems that ensure physicians are not 
discouraged by gatekeepers from offering carotid 
endarterectomy when it is necessary orappropriate, or
from conducting the procedure ifthe patient elects to 
have it. These systems will vary widely, but at the very 
least vascular surgeons who work with or who are 
employed by managed care organizations should help 
them identify through analysis of claims or encounter 
databases all patients who had a transient ischemic 
attack. The vascular surgeon, regardless of whether 
the patient was referred to him, should review the 
medical records of all of these patients to determine 
whether the medical workup was sufficient to identify 
those patients for whom a carotid endarterectomy 
would be a necessary procedure. 
CONCLUSION 
The world of medicine is changing. Until re- 
cently we had no reliable scientific data to support 
the use of carotid endarterectomy itself for any 
patient whatsoever; now we do. There is also a world 
out there that wants to curtail services to patients and 
reduce the cost of medical care. Vascular surgeons 
must assume a leadership role to help ensure that 
carotid endarterectomy produces value for the 
money spent on it and is given to the patients who 
need it. This leadership will require more than com- 
mittee meetings and rhetoric. It will require a will- 
ingness to change the way business is done: 
• Before any patient for carotid endarterectomy 
undergoes the procedure, an explicit assessment 
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of appropriateness and necessity should be 
made by the vascular surgeon, and clinical 
justification should be provided if the patient 
undergoes the procedure but does not meet 
explicit standards of appropriateness and neces- 
sity. This should be a medical decision and not 
an insurance company decision, but it needs to 
be an explicit one. 
• The number of surgeons and hospitals perform- 
ing vascular surgery must be reduced so that 
statistically valid outcome assessments can be 
made. Before surgery, every patient who under- 
goes this procedure should be assessed on the 
basis of  a few standardized clinical variables so 
that both observed and expected outcomes can 
be calculated. Data from this calculation should 
be made available to both the public and to 
referring doctors so that they can rest assured 
that the procedure is being performed in an 
excellent manner. 
• To increase the reliability of  the appropriateness 
decision, new systems to read carotid angiogra- 
phy must be developed and implemented. This 
might include the need to have more than one 
independent reader. 
• An ongoing, population-based system must be 
developed to ensure that the people who would 
benefit from a carotid endarterectomy are of- 
fered the procedure; that the people who re- 
ceive it, receive it for appropriate reasons; and 
that carotid endarterectomies are done by sur- 
geons who perform them well. 
The time for action is now. We can do better. If we 
do not change how we practice medicine, change will 
be forced on us; and that change is likely to be 
concerned only with price. Our patients will do much 
better if we are willing to tackle the above issues 
ourselves and alter the way we do business. 
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